Eva Marina Schmidt
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Liver Disease Diagnosis and Treatment, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile(2010)360 cited
- → γ-Glutamyl-Transpeptidase(1973)196 cited
- → PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer(2018)110 cited
- → Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptors(2012)90 cited
- → Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS Mutations(2017)85 cited
- → Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma(2015)80 cited
- → Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer(2021)66 cited
- → Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15(2008)60 cited
- → Expression of the Hutchinson-Gilford Progeria Mutation during Osteoblast Development Results in Loss of Osteocytes, Irregular Mineralization, and Poor Biomechanical Properties(2012)56 cited
- → Multicolor lineage tracing reveals clonal architecture and dynamics in colon cancer(2017)54 cited